Revenue and Profit Growth
Revenue increased 9.9% to $17.9 million in Q4 2024. Full year revenue was $76.6 million, exceeding the initial target of $74 million. Gross margin improved to 41.2% in Q4 and 37.9% for the full year, surpassing the 35% target.
Earnings Per Share Surge
Fully diluted GAAP EPS increased to $0.93 in Q4 2024, including a $0.37 noncash benefit. Non-GAAP adjusted EPS was $0.61 in Q4, significantly higher than $0.20 in the previous year. Full year non-GAAP adjusted EPS was $2.30, exceeding the revised target of $1.92.
Backlog and Market Momentum
The backlog increased to $21.8 million at the end of 2024, up by $5.8 million from the previous year. The BKR 9000 product showed strong market momentum, particularly in state and local markets.
Strong Balance Sheet
Cash and cash equivalents were $7.1 million with no debt. Working capital improved to $23 million, and shareholders' equity increased to $29.8 million at the end of 2024.
BKR 9000 and New Product Development
The BKR 9000 is gaining traction in the state and local market, expected to drive further growth. Development of the BKR 9500 is underway, expected to generate revenue by 2027.